COST-EFFECTIVENESS OF BOCEPREVIR THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C (HCV) GENOTYPE 1

被引：1
|
作者：
Mernagh, P. [1 ]
Feng, J. [1 ]
Del Cuore, M. [2 ]
机构：
[1] Optum, Sydney, NSW, Australia
[2] Merck Sharp & Dohme Australia, Sydney, NSW, Australia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.440
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A94 / A94
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF BOCEPREVIR-BASED TREATMENT OF CHRONIC GENOTYPE 1 HEPATITIS C VIRUS (HCV) INFECTION FROM THE PERSPECTIVE OF THE GERMAN STATUTORY HEALTH INSURANCE (SHI)
    Becker, B.
    Chhatwal, J.
    Ferrante, S.
    Elbasha, E. H.
    Krobot, K. J.
    VALUE IN HEALTH, 2012, 15 (07) : A392 - A392
  • [22] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [23] Boceprevir targets chronic hepatitis C genotype 1
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (09) : 489 - 489
  • [24] THE COST-EFFECTIVENESS OF HEPATITIS C TREATMENTS IN TREATMENT NAIVE GENOTYPE 1 PATIENTS
    McGinnis, J. J.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A274 - A274
  • [25] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [26] The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
    Myers, RP
    Gregor, JC
    Marotta, PJ
    HEPATOLOGY, 2000, 31 (04) : 834 - 839
  • [27] Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
    Jacobs, RJ
    Koff, RS
    HEPATOLOGY, 2000, 32 (04) : 873 - 874
  • [28] Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
    Myers, RP
    Gregor, JC
    Marotta, PJ
    GASTROENTEROLOGY, 1999, 116 (04) : A1252 - A1252
  • [29] COST-EFFECTIVENESS OF HCV TREATMENT IN GENOTYPE 1 NAIVE PATIENTS IN 2012
    de Ledinghen, V.
    Orsini, M.
    Foucher, J.
    Vergniol, J.
    Chermak, F.
    Messaoudi, N.
    Daures, J. -P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S384 - S385
  • [30] THE COST-EFFECTIVENESS OF TREATMENTS IN NON-CIRRHOTIC SAUDI ARABIAN PATIENTS WITH GENOTYPE 1 AND GENOTYPE 4 CHRONIC HEPATITIS C
    Alowairdhi, M.
    VALUE IN HEALTH, 2018, 21 : S84 - S84
12345